Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Lee Jackson | Dec 23, 2014 at 9:50 AM EST

RBC’s 5 Top Biotech Stocks to Buy for 2015

One sector that could be poised to do well could be the biotech arena, and the team at RBC has…

Chris Lange | Dec 10, 2014 at 10:00 AM EST

Are Investors Signaling Optimism in Biotechs Through Short Interest?

The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top…

Chris Lange | Nov 26, 2014 at 11:07 AM EST

Mixed Readings For Biotech Short Interest

ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Nov 21, 2014 at 10:20 AM EST

5 Health Care Stocks That Need to Play Serious Catch Up

24/7 Wall St. has identified five of the lowest performing health care stocks over the past month which need to…

Chris Lange | Nov 12, 2014 at 8:40 AM EST

Biotech Short Interest Becomes Stock Specific (Updated)

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.

Chris Lange | Oct 27, 2014 at 10:30 AM EDT

Biotech Short Interest Becomes Stock Specific

Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.

Chris Lange | Oct 22, 2014 at 9:05 AM EDT

Biogen Takes Breather on Earnings and MS Drug Sales

Biogen Idec reported better-than-expected third-quarter results before the market opened Wednesday.

Lee Jackson | Oct 21, 2014 at 8:45 AM EDT

Cowen’s Sell-Off Shopping List Loaded With Stocks With Huge Upside Potential

Cowen asked the analysts which stocks should be on their shopping lists. Here are the six with the biggest upside…

Lee Jackson | Oct 16, 2014 at 8:35 AM EDT

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

In a new report, Stifel analysts highlight their top biotech stocks with strong earnings momentum and possible catalysts to buy…

Lee Jackson | Oct 13, 2014 at 8:40 AM EDT

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Rising trends in prescriptions and higher, yet beatable increases in earnings have set the table for what the UBS biotech…

Chris Lange | Oct 10, 2014 at 10:10 AM EDT

Short Interest in Biotech Becomes Company Specific

The short interest data are out for the end of September settlement date, and 24/7 Wall St. has reviewed the…

Lee Jackson | Oct 8, 2014 at 9:00 AM EDT

Deutsche Bank’s Top Stocks to Buy Now for This Quarter and 2015

In a new research report, Deutsche Bank analysts suggest investors focus on sectors like technology, health care, financials and selected…

Lee Jackson | Oct 2, 2014 at 8:55 AM EDT

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.

Jon C. Ogg | Sep 25, 2014 at 10:50 AM EDT

Short Sellers Make Moves in Key Biotech Stocks

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the most…

Chris Lange | Sep 11, 2014 at 9:20 AM EDT

Short Sellers Remain Vigilant Against Biotechs

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest…

1 … 25 26 27 28 29 … 41

Biogen : BIIB

All Biogen Articles

RBC’s 5 Top Biotech Stocks to Buy for 2015

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Mixed Readings For Biotech Short Interest

5 Health Care Stocks That Need to Play Serious Catch Up

Biotech Short Interest Becomes Stock Specific (Updated)

Biotech Short Interest Becomes Stock Specific

Biogen Takes Breather on Earnings and MS Drug Sales

Cowen’s Sell-Off Shopping List Loaded With Stocks With Huge Upside Potential

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Short Interest in Biotech Becomes Company Specific

Deutsche Bank’s Top Stocks to Buy Now for This Quarter and 2015

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

Short Sellers Make Moves in Key Biotech Stocks

Short Sellers Remain Vigilant Against Biotechs

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Biogen : BIIB

All Biogen Articles

RBC’s 5 Top Biotech Stocks to Buy for 2015

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Mixed Readings For Biotech Short Interest

5 Health Care Stocks That Need to Play Serious Catch Up

Biotech Short Interest Becomes Stock Specific (Updated)

Biotech Short Interest Becomes Stock Specific

Biogen Takes Breather on Earnings and MS Drug Sales

Cowen’s Sell-Off Shopping List Loaded With Stocks With Huge Upside Potential

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Short Interest in Biotech Becomes Company Specific

Deutsche Bank’s Top Stocks to Buy Now for This Quarter and 2015

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

Short Sellers Make Moves in Key Biotech Stocks

Short Sellers Remain Vigilant Against Biotechs

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%